Login

Daxas 250 mcg Film-Coated Tablets *

  • Company:

    AstraZeneca Pharmaceuticals (Ireland) DAC

  • Status:

    Updated

  • Legal Category:

    Product subject to medical prescription which may be renewed (B)

  • Active Ingredient(s):

    roflumilast

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

  • undefined
  • undefined
  • undefined
  • undefined

  • What is a Patient Information leaflet and why is it useful?

    A Patient Information Leaflet (PIL) is the leaflet containing information on taking or using a medicine for patients, included with medicine packaging. It is written by pharmaceutical companies as a patient version of the Summary of Product Characteristics (SPC). Changes to the PIL after your medicine was packed may mean the version on medicines.ie may differ from the version found with your medicine.

  • 20210920 Package Leaflet IE MT NI Daxas 250mcg Postpone PASS Final Study Report RSP 21 0011

    Last updated: 24/09/21